REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Gan & Lee Pharmaceuticals. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Gan & Lee Pharmaceuticals. Profile Updated: November 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Gan&Lee Pharmaceuticals is focused on the R&D, production and sales of biopharmaceuticals. The company provides recombinant human insulin analogues and insulin pens. The company was founded in 1998, headquartered in Beijing City, China.

Headquarters
No. 8, Nanfeng West 1st Road, Miao County, Tongzhou District, Beijing
Beijing; Beijing; Postal Code: 101102

Contact Details: Purchase the Gan & Lee Pharmaceuticals. report to view the information.

Website: http://www.ganlee.com.cn

Basic Information
Total Employees:
Purchase the Gan & Lee Pharmaceuticals. report to view the information.
Outstanding Shares:
Purchase the Gan & Lee Pharmaceuticals. report to view the information.
Registered Capital:
Purchase the Gan & Lee Pharmaceuticals. report to view the information.
Financial Auditors:
Purchase the Gan & Lee Pharmaceuticals. report to view the information.
Incorporation Date:
June 17, 1998
Key Executives
Purchase this report to view the information.
Supervisor
Purchase this report to view the information.
Supervisor
Ownership Details
Purchase this report to view the information.
34.61%
Purchase this report to view the information.
8.15%
Purchase this report to view the information.
7.99%
Purchase this report to view the information.
5.41%
Purchase this report to view the information.
1.05%
Subsidiaries
Beijing Dingye Haoda Technology Co., Ltd.
100%
Beijing Gangan Technology Co., Ltd.
100%
G&L HOLDINGS NEW JERSEY INC
100%
Company Performance
Financial values in the chart are available after Gan & Lee Pharmaceuticals. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
17.81%▲
Total operating revenue
26.74%▲
Operating profit (EBIT)
77.25%▲
Net Profit (Loss) for the Period
90.36%▲
Total assets
12.9%▲
Total equity
13.31%▲
Operating Profit Margin (ROS)
8.39%▲
Net Profit Margin
8.62%▲
Return on Equity (ROE)
1.84%▲
Quick Ratio
0.32%▲
Cash Ratio
1.42%▲

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Harbin Gloria Pharmaceuticals Co., Ltd.
 
Guangdong Zhongsheng Pharmaceutical Co.,Ltd.
Hualan Biological Vaccine Inc.
 
Shandong Wit Dyne Health Co.,Ltd.
Cspc Innovation Pharmaceutical. Co. Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo